Delivery Order SPE2DR25D3109-SPE2DR26FT2PD
- Not listed
- The Defense Logistics Agency awarded a $35,035.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This non-set-aside contract is scheduled for completion by January 12, 2026, with performance at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems. The delivery order is...
- The Defense Logistics Agency awarded a $30,931.68 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of January 23, 2026. This firm fixed-price contract, awarded on January 22, 2026, represents a non-set-aside competitive award supporting federal medical procurement. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded a $34,089.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 9, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injector medication. The contract, with an ultimate completion date of January 12, 2026, represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $16,550.52 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 8, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by January 9, 2026, and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating the award was made through full...
- The Defense Logistics Agency awarded a $9,831.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens on January 20, 2026, with completion targeted for January 21, 2026. This non-set-aside delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (which does business as AmerisourceBergen), is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $4,103.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, which is a child order under AmerisourceBergen's parent company Cencora, Inc., carries an ultimate completion date of January 7, 2026, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order was awarded through open competition with...
- The Defense Logistics Agency awarded a delivery order valued at $15,257.84 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract, awarded on January 16, 2026, with an ultimate completion date of January 20, 2026, is a firm fixed-price order with no set-aside designation, reflecting full and open competition. The award represents a task order execution under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $13,410.70 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $10,148.91 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector medication, with performance completion scheduled for November 26, 2025. This is a firm fixed-price delivery order issued under a non-compete, competitively awarded contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $21,556.37 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, competitively awarded contract was issued on December 17, 2025, with an ultimate completion date of December 18, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DR25D3109Indefinite Delivery Contract
- SPE2DR25D3109-SPE2DR26FT2PDDelivery Order
The Defense Logistics Agency awarded a $20,649.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 23, 2026, for Repatha 140 mg/ml SureClick auto-injector pharmaceutical product, with an ultimate completion date of January 26, 2026. This non-set-aside competitive award was fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency. AmerisourceBergen Drug Corp operates as a critical pharmaceutical distributor supporting federal military and healthcare systems through its parent company Cencora, Inc. The company maintains a significant IDC with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the overarching contract vehicle for supplying a comprehensive range of pharmaceutical products, medical supplies, specialty medications, vaccines, and medical devices to support military healthcare programs globally. The present delivery order for Repatha, a specialty cardiovascular medication, demonstrates the company's role in fulfilling critical pharmaceutical needs across the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.6k | 1/22/26 |